Asia Pacific Blepharoplasty Market Size, Share & Industry Trends Analysis Report By Type, By Gender, By End User, By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Blepharoplasty Market should witness market growth of 9.0% CAGR during the forecast period (2022-2028).

One of the most popular cosmetic face surgeries is still blepharoplasty. However, age and genetics may both affect how the orbital region looks. Almost every other facial feature starts to age before the upper lid. While it is not a consequence of aging, familial fat pseudoherniation is shown to begin in the early adolescent years. More than any other facial feature, the eyes command both the patient's and spectators' attention. Whether brought on by inheritance or the consequences of age, eyelid alterations are more significant in the orbital area.

Due to the increasing desire for face procedures worldwide, market participants in the blepharoplasty are anticipated to see strong growth prospects in the following years. Market leaders also strive to provide better and more dependable services to gain more trust with blepharoplasty patients. Due to the availability of highly qualified and specialized personnel who do cosmetic treatments here, they are also developing relationships with hospitals and clinics.

The group also estimated that by 2025, there would be 158.7 million older adults in India and that by 2050, they would outnumber children under 14. The prevalence of wrinkles, fine lines, and other aging signs is predicted to increase considerably in the area with an increase in the older population. The number of persons in the area who were 45 to 64 years old was around 13.5%, or 139,166,661, according to the Office of the Registrar General & Census Commissioner, India. The region's desire for anti-aging therapies has grown as a result of the large number of older people living there. This would increase the need for cosmetic procedures like blepharoplasty in the Asia Pacific region.

The China market dominated the Asia Pacific Blepharoplasty Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $419.7 Million by 2028. The Japan market is estimated to grow a CAGR of 8.4% during (2022-2028). Additionally, The India market would experience a CAGR of 9.7% during (2022-2028).

Based on Type, the market is segmented into Upper Eyelid, Lower Eyelid and Combination Eyelid Surgery. Based on Gender, the market is segmented into Female and Male. Based on End-user, the market is segmented into Hospitals, Clinics and Ambulatory Surgical Centre. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Sisram Medical Ltd (Fosun Pharma), AbbVie, Inc., LightScalpel, Inc, Surgical Holdings, GRAND AESPIO, INC., London Bridge Plastic Surgery, Medline Industries, Inc., and Lumenis Be Ltd.

Scope of the Study

By Type

• Upper Eyelid
• Lower Eyelid
• Combination Eyelid Surgery

By Gender

• Female
• Male

By End-user

• Hospitals
• Clinics
• Ambulatory Surgical Centre

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Medtronic PLC
• Sisram Medical Ltd (Fosun Pharma)
• AbbVie, Inc.
• LightScalpel, Inc
• Surgical Holdings
• GRAND AESPIO, INC.
• London Bridge Plastic Surgery
• Medline Industries, Inc.
• Lumenis Be Ltd.

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free